19 May 2013
Keywords: pfizer/cambridge, combinatorial, deals, uk-based, oxford, molecular, subsidiary
Article | 28 June 1999
UK-based Oxford Molecular subsidiary Cambridge Combinatorial has signeda series of three deals, covering medicinal chemistry and process R&D, with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.